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Abstract
Purpose The purpose of this study was to explore self-esteem and associations between self-esteem and sociodemographic, 
clinical, and psychological factors in patients with inflammatory bowel disease (IBD), a disease of chronic relapsing inflam-
mation of the gastrointestinal tract. IBD symptoms, including pain, fatigue, and diarrhea, as well as potential life-long medical 
treatment and surgery, may be demanding, cause significant challenges, and influence self-esteem.
Methods In this cross-sectional multicenter study, participants were recruited from nine hospitals in the southeastern and 
western regions of Norway from March 2013 to April 2014. Data were collected using self-report questionnaires. Self-
esteem was assessed by the Rosenberg Self-Esteem Scale, fatigue was assessed by the Fatigue Questionnaire, self-efficacy 
was assessed by the General Self-Efficacy Scale, and disease activity was assessed by the Simple Clinical Colitis Activity 
Index for ulcerative colitis (UC) and Harvey Bradshaw Index for Crohn’s disease (CD). Multiple linear regression analysis 
was applied to examine associations between self-esteem and sociodemographic, clinical, and psychological factors.
Results In total, 411 of 452 (91%) patients had evaluable data and were included in this study. The mean scores on self-
esteem, self-efficacy, total fatigue, anxiety, and depression were similar between UC patients and CD patients. Male gender, 
being employed, and higher self-efficacy were independently associated with higher self-esteem, whereas anxiety and 
depression were independently associated with lower self-esteem. Neither disease activity nor fatigue were associated with 
self-esteem in the final multiple regression analyses.
Conclusion Patient-centered interventions that improve self-esteem and reduce anxiety and depression seem to be important 
to optimize IBD management.
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Introduction
Chronic disease and its consequences may be a threat to 
personal and social identity and, in particular, a person’s 
self-esteem. Inflammatory bowel disease (IBD), which 
includes ulcerative colitis (UC) and Crohn’s disease (CD), 
is characterized by chronic inflammation of the gastroin-
testinal tract and results in recurrent symptoms such as 
abdominal pain and diarrhea, often with blood and mucus. 
In addition, patients may have systemic symptoms such 
as lack of appetite, weight loss, and fatigue, and a high 
proportion also report psychological comorbidities such as 
anxiety and depression [1–3]. IBD and its complications 
may have severe consequences for those afflicted, includ-
ing frequent hospitalizations, surgery, sick leave, and an 
increased risk of work disability [4]. Disease onset is usu-
ally in adolescence/early-adulthood (15–35 years). Living 
with IBD may consequently be demanding and stressful, 
and it has been well demonstrated that IBD may negatively 
affect patients’ health-related quality of life (HRQoL) [5, 
6].
For patients with IBD, symptoms may be experienced 
as socially embarrassing and as a stressor, which in turn 
has the potential to shape patients’ emotions, beliefs, and 
behaviors [7]. Indeed, it has been reported that IBD patients 
perceive that others hold stigmatizing views toward them 
and the disease, i.e., they feel different from others, shame, 
and discredited. Moreover, IBD stigma is associated with 
poorer health outcomes and exacerbates lower self-esteem 
and feelings of depression or anxiety [8].
Self-esteem is a self-concept that refers to the positive 
and negative feelings and evaluations we have about our-
selves and represents our sense of self-worth [9]. While 
self-esteem may be threatened by the experience of various 
disease-related consequences, high self-esteem can be an 
important prerequisite for coping [10]. Previous research has 
shown that higher self-esteem is associated with a more pos-
itive affect in persons with chronic illness [11], and it buff-
ers against depression, stress, and other negative emotions 
[11–13]. In adult IBD populations, studies on self-esteem are 
scarce, but stigma and body image dissatisfaction have been 
associated with lower self-esteem [8, 14–16]. In adolescents 
with IBD, self-esteem has been evaluated in several stud-
ies, and a meta-analysis revealed no significant differences 
in self-esteem between patients with IBD, healthy controls, 
and patients with other chronic diseases [13]. However, a 
more severe disease course has been found to be associated 
with lower self-esteem among adolescent IBD patients [17]. 
Previous studies have used self-esteem largely as a predictor 
variable and not as an outcome variable. We have not been 
able to find studies exploring factors associated with self-
esteem in adult IBD populations.
Thus, the aim of this study was to explore self-esteem 
in an adult IBD population and to investigate associations 




In this cross-sectional study, participants were recruited 
from nine hospitals in the southeastern and western regions 
of Norway as part of an observational, multicenter study. 
The inclusion period lasted from March 2013 to April 2014. 
Inclusion criteria were age > 17 years; a verified diagnosis 
of IBD based on endoscopic, laboratory, and histological 
findings according to the Lennard–Jones criteria [18]; and 




Sociodemographic variables were self-reported by patients 
and included age, gender, marital status, educational level, 
work status, and smoking status. Clinical data were collected 
by interview, from medical records and from laboratory 
tests. The disease phenotype was classified according to the 
Montreal classification [19]. Disease activity was assessed 
through two disease activity indices: the Simple Clinical 
Colitis Activity Index (SCCAI) for UC [20] and the Harvey 
Bradshaw Index (HBI) for CD [21].
Patient‑reported outcomes
Rosenberg self‑esteem scale
The Rosenberg Self-Esteem Scale (RSES) [22] assesses the 
patients’ global self-esteem and addresses overall feelings 
of self-worth and acceptance [9]. The RSES consists of ten 
statements with responses ranked from 1 ‘strongly agree’ 
to 4 ‘strongly disagree.’ The total score is the sum of item 
responses and ranges from 10 to 40, with higher scores rep-
resenting higher self-esteem. The RSES has been translated 
into Norwegian and validated [23].
The fatigue questionnaire
The Fatigue Questionnaire (FQ) was developed by Chalder 
et al. [24] and has been translated into Norwegian and vali-
dated [25]. The FQ consists of 11 items. Responses are based 
on four options (0 = better than usual, 1 = no more than usual, 
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2 = worse than usual, and 3 = much worse than usual), and the 
dichotomized item scores were 0 for item response values 0 or 
1 and 1 for item response values 1 or 2. Higher scores indicate 
higher levels of fatigue [24, 25].
The general self‑efficacy scale
The General Self-Efficacy Scale (GSE) [26] measures a per-
son’s optimistic self-beliefs in coping with the demands of 
life. The GSE consists of 10 statements that the respondents 
rate from 1 “completely agree” to 4 “completely disagree.” 
The GSE total score is calculated by summing each individual 
score (range 10 to 40). A higher score indicates stronger self-
efficacy. The GSE has high reliability and validity [27].
Hospital anxiety and depression scale
The Hospital Anxiety and Depression Scale (HADS) was 
developed to assess anxiety and depression among diverse 
clinical and nonclinical hospital populations [28]. The HADS 
contains 14 questions, each of which is scored on a Likert 
scale from 0 to 3. The HADS subscales for anxiety (HADS-A) 
and depression (HADS-D) are scored between 0 and 21. The 
HADS has been translated into Norwegian, and this version 
has been validated [29].
Statistical analysis
Differences between groups were assessed with the chi-square 
(χ2) test for categorical data and the independent sample t test 
for continuous variables with normal distributions. When 
the continuous variables had skewed distributions, they were 
described with medians and ranges, and differences between 
groups were tested using the nonparametric Mann–Whit-
ney U test. Multiple linear regression analyses were used to 
determine the associations between self-esteem (dependent 
variable) and relevant sociodemographic, clinical, and psy-
chological (independent) variables. In addition to gender and 
age, variables with p values < 0.15 in the univariate analyses 
were entered into a multiple linear regression model. None of 
the independent variables included in the final analyses were 
highly correlated (Pearson’s correlation coefficient > 0.7) with 
any other possible variable; thus, we assumed no multicollin-
earity. All tests were two-sided and analyzed using Statistical 
IBM SPSS Statistics for Windows version 25.0 (IBM Corp., 
Armonk, NY, released in 2017).
Results
Study sample
Of the 452 patients invited to participate in the study, 414 
patients (91.6%) gave written informed consent. Three 
patients were excluded due to missing data, bringing the 
number included in the analyses to 411 (91%). No signifi-
cant differences in gender or age were found between the 
patients excluded due to missing data and those included 
in the analyses (data not shown).
Patient characteristics are presented in Table 1. There 
were no significant differences between UC and CD 
patients with regard to age, gender, education level, or 
civil status. However, compared to UC patients, a higher 
proportion of CD patients were unemployed, had longer 
disease duration, and a higher proportion had undergone 
gastrointestinal surgery, including 15 patients with an ile-
ostomy. The mean self-esteem, self-efficacy, total fatigue, 
anxiety, and depression scores were comparable between 
the two groups.
Univariate and multiple associations 
with self‑esteem
The univariate and multiple associations with self-esteem 
are shown in Table 2 for UC patients and Table 3 for CD 
patients. In both disease groups, increased self-esteem was 
associated with male gender, being employed and higher 
self-efficacy. Furthermore, lower self-esteem was associated 
with anxiety, depression, total fatigue, and disease activity. 
In addition, lower self-esteem was associated with gastroin-
testinal surgery in UC patients, and higher self-esteem was 
associated with being in a relationship and with a higher 
educational level in CD patients.
The multiple linear regression analyses showed, in both 
UC and CD patients, that higher self-efficacy scores and 
male gender were independently associated with higher self-
esteem. In UC patients, being employed was additionally 
independently associated with higher self-esteem. Increased 
anxiety and depression scores were independently associated 
with lower self-esteem. Clinical factors and fatigue were not 
significantly associated with self-esteem in the final regres-
sion analyses.
Discussion
The key findings in this study were that male gender, being 
employed, and higher self-efficacy were associated with 
higher self-esteem, whereas anxiety and depression were 
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Table 1  Characteristics of IBD 
patients
IBD inflammatory bowel disease; UC ulcerative colitis; CD Crohn’s disease; HBI Harvey Bradshaw Index; 
SCCAI Simple Clinical Colitis Activity Index. †Upper tract modifier and perianal disease coexist with 
other location categories
Continuous variables were estimated by student’s t test and the Mann–Whitney U test, and the Chi-squared 
test (X2) was used to compare proportions. p value estimated between CD and UC patients
Characteristics IBD (n = 411) UC (n = 180) CD (n = 231) p value
Sociodemographic characteristics
Age (Mean, SD) 40.72 (12.77) 40.75 (12.57) 40.70 (12.96) 0.97
Gender n (%)
  Female 202 (49) 87 (48) 115 (50) 0.77
  Male 209 (51
Education
  University degree n, (%) 175 (43) 80 (45) 95 (41) 0.44
  High school 234 (57) 98 (55) 136 (59)
Civil status n (%)
  Married 322 (78.2) 146 (81) 176 (76) 0.19
  Divorced, unmarried, widow(er) 88 (22) 33 (18) 55 (24)
Work status n (%)
  Working/student 277 (68) 131 (73) 146 (63) 0.33
  Not working 133 (32) 48 (27) 85 (37)
Clinical characteristics
  HBI (Median, range) 4 (0 to 24)
  SCCAI (Median, range) 3 (0 to 17)
Disease duration
  Median (range) 9 (0 to 50) 6 (0 to 46) 11 (0 to 50)  < 0.001
Location n (%)
  L1 terminal ileum 75 (32.5)
  L2 colonic 48 (20.8)
  L3 ileocolonic 76 (32.9)
  L4 upper tract only or modifier† 32
Behavior n (%)
  B1 inflammatory 118 (51)
  B2 stricturing 83 (36)
  B3 penetrating 30 (13)
  Perianal† (yes) 51
Extent n (%)
  E1 proctitis 20 (11.1)
  E2 left-sided 58 (32.2)
  E3 extensive 102 (56.7
On medication n (%)
  Biological 167 (40) 53 (29) 114 (49)
  Immunomodulator 136 (33) 47 (26) 89 (39)
Gastrointestinal surgery n (%)
  Yes 10 (6) 108 (47)
  No 170 (94) 123 (53)  < 0.01
Ileostomy 15 (3.6) 2 (1) 13 (5.6)
Psychological factors
  Self-esteem (Mean, SD) 30.39 (4.7) 30.58 (4.5) 30.24 (4.9)
  Self-efficacy (Mean, SD) 29.35 (5.8) 29.23 (5.7) 29.43 (5.8)
  HADS–Anxiety (Mean, SD) 6.04 (3.7) 6.29 (3.7) 5.84 (3.7)
  HADS–Depression (Mean, SD) 3.79 (3.8) 3.70 (3.3) 3.86 (3.3)
  Total fatigue score (Mean, SD) 15.9 (5.4) 16.1 (5.2) 15.8 (5.6)
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associated with lower self-esteem. Clinical factors were not 
associated with self-esteem.
The mean self-esteem score found among the IBD 
patients in our study (30, range 15–40) is comparable to 
previously reported findings in an adult IBD population 
(mean self-esteem score of 33; range 27–34) [30] and to 
patients with irritable bowel syndrome (mean self-esteem 
score 30; range 24–36) [30] and multiple sclerosis (mean 
self-esteem score 29; range 16–40) [31]. This may suggest 
that some factors contributing to the level of self-esteem 
are common across diseases, such as anxiety, depression, 
and self-efficacy.
The strong association between self-efficacy and self-
esteem found in this study is in line with self-concept theo-
ries [32] and results from earlier research in a variety of 
chronic disease populations [31, 33, 34]. The direction of 
the associations found in our study cannot be evaluated due 
to the cross-sectional study design. However, self-efficacy 
Table 2  Univariate and multiple 
linear regression analyses with 
self-esteem as the dependent 
variable in patients with 
ulcerative colitis (n = 180)
β, estimated beta coefficient = association with self-esteem while controlling for all other variables in the 
final regression model. In addition to gender and age, variables in the univariate analyses with p < 0.15 
were included in the final regression model
Coding Gender, men = 0, women = 1; education level, <  = 12  years = 0, >  12  years = 1; civil status, mar-
ried/in a relationship = 0, divorced/unmarried/widow(er) = 1; work status, working/student = 0, not work-
ing = 1; gastrointestinal surgery, no = 0, yes = 1
Variable Univariate Multiple
β (95% CI) p value β (95% CI) p value
Age 0.03 (-0.02,0.08) 0.25 0.02 (-0.02,0.07) 0.33
Gender  − 2.57 (− 3.86, 1.29)  < 0.001  − 1.45 (− 2.55, 0.34) 0.01
Education level 0.99 (− 0.36,2.35) 0.15 0.43 (− 0.63,1.50) 0.43
Civil status  − 0.66 (− 2.40,1.09) 0.46  −  − 
Work status  − 2.43 (− 3.89, 0.97) 0.001  − 1.25 (− 2.52,0.01) 0.05
Disease activity  − 0.40 (− 0.61, − 0.20)  < 0.001  − 0.03 (− 0.23,0.17) 0.76
Gastrointestinal surgery  − 2.95 (− 5.80, 0.10) 0.03  − 1.29 (− 3.76,1.08) 0.29
Disease duration 0.00 (− 0.80,0.84) 0.96  −  − 
Anxiety  − 0.60 (− 0.76, 0.45)  < 0.001  − 0.29 (− 0.47, 0.10) 0.003
Depression  − 0.60 (− 0.79, 0.42)  < 0.001  − 0.26 (− 0.47, 0.05) 0.01
Total fatigue  − 0.29 (− 0.41, 0.17)  < 0.001  − 0.01 (− 0.14, 0.05) 0.92
Self-efficacy 0.39 (0.29,0.49)  < 0.001 0.26 (0.16,0.35)  < 0.001
Table 3  Univariate and multiple 
linear regression analyses with 
self-esteem as the dependent 
variable in patients with Crohn’s 
disease (n = 231)
β, estimated beta coefficient = association with self-esteem while controlling for all other variables in the 
final regression model. In addition to gender and age, variables in the univariate analyses with p < 0.15 
were included in the final regression model
Coding Gender, men = 0, women = 1; education level, <  = 12 years = 0, > 12 years = 1; civil status, married/
in a relationship = 0, divorced/unmarried/widow(er) = 1; work status, working/student = 0, not working = 1; 
gastrointestinal surgery, no = 0, yes = 1
Variable Univariate Multiple
β (95% CI) p value β (95% CI) p value
Age 0.03 (− 0.02,0.08) 0.27 0.006 (− 0.03,0.04) 0.76
Gender  − 2.55 (− 3.81, 1.29)  < 0.001  − 1.87 (− 2.86, 0.88)  < 0.001
Education level 1.38 (0.06,2.69) 0.04 0.11 (− 0.82,1.04) 0.82
Civil status  − 1.66 (− 3.19, 0.12) 0.03  − 0.72 (− 1.81,0.38) 0.20
Work status  − 2.19 (− 3.52, 0.86) 0.001 0.19 (− 0.90,1.28) 0.73
Disease activity  − 0.36 (− 0.50, 0.17)  < 0.001 0.006 (− 0.13,0.14) 0.93
Gastrointestinal surgery 0.14 (− 1.45,1.17) 0.83  −  − 
Disease duration 0.007 (− 0.06,0.07) 0.84  −  − 
Anxiety  − 0.58 (− 0.73, 0.42)  < 0.001  − 0.16 (− 0.31, 0.01) 0.03
Depression  − 0.83 (− 1.00, 0.66)  < 0.001  − 0.51 (− 0.69, 0.34)  < 0.001
Total fatigue  − 0.31 (− 0 − 42, 0.21)  < 0.001  − 0.05 (− 0.15,0.05) 0.31
Self- efficacy 0.48 (0.39,0.57)  < 0.001 0.37 (0.28,0.45)  < 0.001
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influences people’s choices and behavior [35]; thus, it may 
be hypothesized that self-esteem impacts a person’s belief 
in their ability to accomplish a specific goal or task (self-
efficacy) [31]. In this way, self-esteem may be threatened by 
experiencing illness-related consequences or by decreased 
coping with everyday life challenges. To account for the 
variability in disease-related demands and illness-related 
concerns between different chronic diseases, an IBD-spe-
cific self-efficacy scale has been developed and validated for 
patients in both adult and adolescent populations [36–38]. 
The scale relates to the unique self-management require-
ments of IBD patients, such as managing stress and emo-
tions, managing medical care, managing symptoms and 
disease, and maintaining remission [36]. The strong rela-
tionship between self-esteem and self-efficacy found in our 
study indicates that they are both important constructs in 
disease management. When developing targeted interven-
tions, it may be important to include both self-efficacy and 
self-esteem to identify areas where IBD patients may need 
more support for self-management, such as in transitioning 
from pediatric to adult care, developing emotional coping 
skills, and navigating medical care. Self-esteem and self-
efficacy are also positively associated with other personal 
characteristics, such as sense of coherence, internal locus 
of control, achievement motivation, self-control, optimism, 
satisfaction, and emotional stability [35, 39].
The strong negative relationship between self-esteem and 
depression and anxiety found in our study is consequently 
not surprising and aligns with prior studies. In a meta-anal-
ysis including 77 longitudinal studies, low self-esteem pre-
dicted symptoms of depression and anxiety across gender, 
age, and populations [40]. The strongest relationship was 
found between low self-esteem and depression [41]. Several 
theoretical frameworks explain this relationship, suggesting 
that self-esteem has an important role in a person’s positive 
and negative affective state and that low self-esteem is a 
vulnerability factor for the development of depression [9, 40, 
42]. This is important for patients with IBD because large 
cohort studies have shown that their rates of depression are 
significantly higher compared to healthy populations [43]. 
Furthermore, a systematic review revealed that both anxi-
ety and depression are associated with clinical factors such 
as a more severe disease course, increased disease activity, 
more frequent disease flares, and increased hospitalization 
rates, [3, 43], all of which cause disease unpredictability and 
impact patients’ daily functioning and HRQoL. This shows 
that there is a need to strengthen disease management by 
including evidence-based individualized psychosocial sup-
port in routine follow-up and care [44].
Fatigue was associated with lower self-esteem in the 
univariate analysis. Increased fatigue scores have been con-
sistently related to depressive symptoms in previous IBD 
studies (45–46). As self-esteem was strongly associated with 
depression in the current study, one might expect a rela-
tionship between increased fatigue and lower self-esteem as 
well. However, in the final regression analyses, neither total 
fatigue scores nor the mental and physical fatigue subscores 
were independently associated with self-esteem [45, 46]. To 
our knowledge, our study is the first to evaluate the associa-
tion between self-esteem and fatigue in an IBD population. 
The ability to controlling for interactions between fatigue 
and depression in the multiple regression analyses may have 
elucidated the effect of fatigue on self-esteem.
Male gender and being employed were factors inde-
pendently associated with higher self-esteem in our study. 
The fact that males reported higher levels of self-esteem 
than females is consistent with previous research [23, 47]. 
Employment is associated with feelings of worthiness and 
societal usefulness, income, and autonomy, and is thus an 
important element in a person’s identity. Education level 
and being in a relationship were associated with higher 
self-esteem in the univariate analysis but not in the final 
regression models. This finding is in contrast to results from 
a study of the general population in Norway, which found 
lower socioeconomic status, not having a cohabiting partner, 
unemployment, and disability were each uniquely associated 
with lower levels of self-esteem [41]. However, the direction 
of the associations was unclear. It may be that high self-
esteem influences socioeconomic status.
Clinical factors (disease activity, gastrointestinal surgery, 
having an ileostomy) did not independently influence self-
esteem in our study. This is in line with a previous study 
of IBD patients [30]. The impact of disease symptoms and 
physical consequences of IBD have been shown in earlier 
studies to affect psychological and social well-being [48]. 
Patients with higher disease activity reported lower self-
efficacy and increased psychological distress in a study of 
IBD patients using the disease-specific self-efficacy scale 
in two different samples of IBD patients: one online sam-
ple recruited through websites and one outpatient sample. 
Thus, it could be hypothesized that disease activity also 
affects the level of self-esteem. Having ongoing disease 
symptoms such as diarrhea, bowel incontinence, and urge 
can be embarrassing and can affect someone’s interest in 
socializing. Lower self-esteem predicted more symptom 
interference and reported activity restrictions in a study of 
patients with rheumatoid arthritis and asthma [11]. How-
ever, we did not ask the patients about symptom burden or 
whether the symptoms interfered with daily functioning or 
well-being. Furthermore, in our study, nearly one-third of 
the IBD patients had undergone gastrointestinal surgery, and 
15 patients had an ileostomy. In a study by Taft et al. [16], 
patients reported that disease symptoms such as diarrhea, 
bowel sounds, bowel incontinence, and urge were embar-
rassing and that gastrointestinal surgery affected the patient’s 
body image. However, there were no significant differences 
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in self-esteem scores between the IBD patients with and 
without ileostomy. We did not assess body image concerns 
in our study, which could add important information to 
explain these relationships.
The study has some limitations. The complex relation-
ships between the factors examined in this study could not 
be well explored using a cross-sectional sign. It may be that 
self-esteem varies over time depending on social, psycho-
logical, and clinical status. A longitudinal design may pro-
vide a better understanding of how these different factors 
relate to each other. Moreover, we did not assess body image 
concerns, which could add important information to the find-
ings in our study.
Conclusion
In this adult IBD population, self-esteem was strongly asso-
ciated with male gender, anxiety, depression, and self-effi-
cacy but not with clinical factors. Patients with IBD vary 
by disease type, disease severity, surgical history, and soci-
odemographic and psychological presentation. Therefore, 
the care and follow-up of patients need to be individual-
ized. Regardless of diagnosis, psychological factors were 
the strongest contributors to the variance in self-esteem in 
our study. Patient-centered interventions that improve self-
esteem and reduce anxiety and depression seem to be impor-
tant to optimize IBD management.
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